These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8067050)

  • 1. The immunopathogenesis of equine infectious anemia virus.
    Sellon DC; Fuller FJ; McGuire TC
    Virus Res; 1994 May; 32(2):111-38. PubMed ID: 8067050
    [No Abstract]   [Full Text] [Related]  

  • 2. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine infectious anemia.
    Henson JB; McGuire TC
    Prog Med Virol; 1974; 18(0):143-59. PubMed ID: 4371283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Equine infectious anemia--recent researches and prospect of the study (author's transl)].
    Kono Y
    Uirusu; 1973 Mar; 23(1):1-12. PubMed ID: 4356439
    [No Abstract]   [Full Text] [Related]  

  • 5. Unsuccessful attempts to propagate equine infectious anemia virus in lambs and small experimental animals.
    Kono Y; Taniguchi T
    Natl Inst Anim Health Q (Tokyo); 1974; 14(4):206-7. PubMed ID: 4375794
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease induction by virus derived from molecular clones of equine infectious anemia virus.
    Payne SL; Qi XM; Shao H; Dwyer A; Fuller FJ
    J Virol; 1998 Jan; 72(1):483-7. PubMed ID: 9420249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of horses against equine infectious anemia (EIA) with an attenuated EIA virus.
    Kono Y; Kobayashi K; Fukunaga Y
    Natl Inst Anim Health Q (Tokyo); 1970; 10(3):113-22. PubMed ID: 4320652
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the host immune response in selection of equine infectious anemia virus variants.
    Carpenter S; Evans LH; Sevoian M; Chesebro B
    J Virol; 1987 Dec; 61(12):3783-9. PubMed ID: 2446008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
    Zhang W; Lonning SM; McGuire TC
    J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses.
    Ricotti S; Garcia MI; Veaute C; Bailat A; Lucca E; Cook RF; Cook SJ; Soutullo A
    Vet Microbiol; 2016 May; 187():41-49. PubMed ID: 27066707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titration of equine infectious anemia virus. Effect of dosage on incubation time and clinical signs.
    Kemeny LJ; Mott LO; Pearson JE
    Cornell Vet; 1971 Oct; 61(4):687-95. PubMed ID: 4330637
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody escape kinetics of equine infectious anemia virus infection of horses.
    Schwartz EJ; Nanda S; Mealey RH
    J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine infectious anemia and equine infectious anemia virus in 2013: a review.
    Cook RF; Leroux C; Issel CJ
    Vet Microbiol; 2013 Nov; 167(1-2):181-204. PubMed ID: 24183747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.
    Chong YH; Ball JM; Issel CJ; Montelaro RC; Rushlow KE
    J Virol; 1991 Feb; 65(2):1013-8. PubMed ID: 1846180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of antigenic variation by the equine infectious anemia virus.
    McGuire TC; O'Rourke K; Cheevers WP
    Contrib Microbiol Immunol; 1987; 8():77-89. PubMed ID: 3040337
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of EIAV immunogenicity during persistent infections: humoral responses and antigen targets.
    Montelaro RC; Ball JM; Issel CJ
    Dev Biol Stand; 1990; 72():19-30. PubMed ID: 1704323
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus.
    Banks KL; Henson JB; McGuire TC
    Lab Invest; 1972 Jun; 26(6):701-7. PubMed ID: 4337973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.